Wed, Apr 04, 2013 at 16:30 PM
Markets slumped, amid political uncertainity.
Markets after opening gap down in the morning could not recover and slumed further in noon session and ended firm negative, due to heavy sellings across the sectors, amid political uncertainity. Sensex closed down by 291.94 or 1.55% at 18,509.70 after opening gap down by 70.26 points or 0.37% at 18,731.38 and touched a high of 18,733.62 and a low of 18,473.82 while Nifty ended down by 98.15 points or 1.73% at 5,574.75 after opening down by 32.25 points or 0.57% at 5,640.65 and stroked a high of 5,644.45 and a low of 5,565.65 in the day.
Sectoral wise, all sector closed negative with Realty index leading the list slumped by 3.39%, following the trend were IT and Consumer Durables dropped by 2.45% and 2.05%, Bankex, Metal, Power, Capital Goods, FMCG and Oil & Gas indices declined between 2%-1% each, PSU dropped down by 0.61%, Healthcare fell by 0.52% and Auto index down by 0.42%. In broader markets, both the indices Mid-cap and Small-cap too slumped by 1.84% and 2.08% respectively.
Major stock gainers were, Dr. Reddys Laboratories surged up by 3.03%, Coal India Limited gainied up by 2.56%, Hindustan Unilever up by 1.68%, Maruti Suzuki advanced up by 1.06% while Mahindra & Mahindra and Tata Motors Limited marginally up by 0.26% and 0.08% respectively.
Major stock losers were, Jindal Steel & Power Limited slumped by 4.32%, Tata Steel Limited and Sterlite Industries dropped by 3.97% and 3.09%, Infosys, Hero Motocorp, ITC, Bharti Airtel, Hindalco Industries, Tata Consultancy Services, BHEL, HDFC and ICICI Bank Limited declined between 3%-2% each, State Bank of India, Cipla Limited, HDFC Bank, Larsen & Toubro, Tata Power Company, Reliance Industries Limited, Bajaj Auto and Wipro Limited fell between 2%-1% respectively, ONGC fell by 0.93%, Gail (India) down by 0.76%, NTPC down by 0.62% and Sun Pharmaceuticals fell by 0.55%.
Indraprastha Gas dipped by 2.70%, on reports of Supreme Court deferring its case hearing against Petroleum and Natural Gas Regulatory Board till April 16 2013.
Dr Reddys Laboratories surged up by 3.03% after company launched Zoledronic acid injection in the US market following approval by the USFDA (United States Food & Drug Administration).
Overall market breadth was firm negative with 1,850 shares declined compared to 907 shares advanced while 111 shares remained unchanged.
No comments:
Post a Comment